139 related articles for article (PubMed ID: 30170089)
21. A Cost Analysis of Phosphodiesterase Type 5 Inhibitors in the United States.
Nabavizadeh B; Nguyen A; Li D; van Meijgaard J; Breyer BN
Urology; 2024 Jan; 183():127-133. PubMed ID: 37951363
[TBL] [Abstract][Full Text] [Related]
22. Variation in cash price of the generic medications most prescribed by dermatologists in pharmacies across the United States.
Alghanem N; Abokwidir M; Fleischer AB; Feldman SR; Alghanem W
J Dermatolog Treat; 2017 Mar; 28(2):119-128. PubMed ID: 27241622
[TBL] [Abstract][Full Text] [Related]
23. The price may not be right: the value of comparison shopping for prescription drugs.
Arora S; Sood N; Terp S; Joyce G
Am J Manag Care; 2017 Jul; 23(7):410-415. PubMed ID: 28817779
[TBL] [Abstract][Full Text] [Related]
24. Pharmacy and neighborhood-level variation in cash price of diabetes medications in the United States.
Warraich HJ; Siddiqi HK; Li DG; van Meijgaard J; Vaduganathan M
PLoS One; 2023; 18(12):e0294164. PubMed ID: 38060500
[TBL] [Abstract][Full Text] [Related]
25. Factors affecting bargaining outcomes between pharmacies and insurers.
Brooks JM; Doucette W; Sorofman B
Health Serv Res; 1999 Apr; 34(1 Pt 2):439-51. PubMed ID: 10199687
[TBL] [Abstract][Full Text] [Related]
26. Naloxone Deserts in NJ Cities: Sociodemographic Factors Which May Impact Retail Pharmacy Naloxone Availability.
Lozo KW; Nelson LS; Ramdin C; Calello DP
J Med Toxicol; 2019 Apr; 15(2):108-111. PubMed ID: 30805884
[TBL] [Abstract][Full Text] [Related]
27. Pharmacy discounts on generic medicines in France: is there room for further efficiency savings?
Kanavos P; Taylor D
Curr Med Res Opin; 2007 Oct; 23(10):2467-76. PubMed ID: 17764613
[TBL] [Abstract][Full Text] [Related]
28. Availability and Cost of Expensive and Common Generic Prescription Drugs: A Cross-sectional Analysis of Direct-to-Consumer Pharmacies.
Lalani HS; Tessema FA; Kesselheim AS; Rome BN
J Gen Intern Med; 2024 Feb; ():. PubMed ID: 38321315
[TBL] [Abstract][Full Text] [Related]
29. Variability in Retail Pricing of Generic Drugs for Heart Failure.
Hauptman PJ; Goff ZD; Vidic A; Chibnall JT; Bleske BE
JAMA Intern Med; 2017 Jan; 177(1):126-128. PubMed ID: 27846638
[No Abstract] [Full Text] [Related]
30. Retail cost of antiglaucoma drugs in two cities.
Ritch R; Hargett N; Podos S; Kass MA; Becker B
Am J Ophthalmol; 1978 Jul; 86(1):1-7. PubMed ID: 677219
[TBL] [Abstract][Full Text] [Related]
31. Do generics offer significant savings to the UK National Health Service?
Kanavos P
Curr Med Res Opin; 2007 Jan; 23(1):105-16. PubMed ID: 17257472
[TBL] [Abstract][Full Text] [Related]
32. Availability and variation of publicly reported prescription drug prices.
Kullgren JT; Segel JE; Peterson TA; Fendrick AM; Singh S
Am J Manag Care; 2017 Jul; 23(7):444-448. PubMed ID: 28817781
[TBL] [Abstract][Full Text] [Related]
33. Reforming the Swedish pharmaceuticals market: consequences for costs per defined daily dose.
Bergman MA; Granlund D; Rudholm N
Int J Health Econ Manag; 2016 Sep; 16(3):201-214. PubMed ID: 27878673
[TBL] [Abstract][Full Text] [Related]
34. Price variation in the most commonly prescribed ear drops in Southern California.
Moshtaghi O; Haidar YM; Ghavami Y; Gu J; Moshtaghi A; Sahyouni R; Huang M; Lin HW; Djalilian HR
Laryngoscope; 2017 Aug; 127(8):1780-1784. PubMed ID: 28120334
[TBL] [Abstract][Full Text] [Related]
35. The effect of a generic drug law on the retail cost of antiglaucoma medications.
Kass MA; Gordon M
Am J Ophthalmol; 1981 Aug; 92(2):273-8. PubMed ID: 7270645
[TBL] [Abstract][Full Text] [Related]
36. A comparison of mail-service and retail community pharmacy claims in 5 prescription benefit plans.
Clark BE; Siracuse MV; Garis RI
Res Social Adm Pharm; 2009 Jun; 5(2):133-42. PubMed ID: 19524861
[TBL] [Abstract][Full Text] [Related]
37. Analysis of Spanish generic medicines retail market: recommendations to enhance long-term sustainability.
Dylst P; Vulto AG; Simoens S
Expert Rev Pharmacoecon Outcomes Res; 2014 Jun; 14(3):345-53. PubMed ID: 24758569
[TBL] [Abstract][Full Text] [Related]
38. Increased topical generic prices by manufacturers.
Bhatt MD; Bhatt BD; Dorrian JT; McLellan BN
J Am Acad Dermatol; 2019 May; 80(5):1353-1357. PubMed ID: 29544742
[TBL] [Abstract][Full Text] [Related]
39. Undocumented source of pharmacy benefit manager revenue.
Siracuse MV; Clark BE; Garis RI
Am J Health Syst Pharm; 2008 Mar; 65(6):552-7. PubMed ID: 18319501
[TBL] [Abstract][Full Text] [Related]
40. Gross profits of Canadian pharmacies: A changing policy regime.
Thanh NX; Jacobs P; Husereau D
Healthc Manage Forum; 2020 Sep; 33(5):228-232. PubMed ID: 32552055
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
